OIG - G2 Intelligence

OIG Report on Lab Testing Should Prompt Compliance Review

by Scott Wallask | Mar 16, 2026 | Coding-lca, Compliance-lca, Compliance-nir, Essential, Lab Industry Advisor, OIG-nir, Reimbursement-lca, Reimbursement-lir, Reimbursement-nir

Genetic testing now accounts for 43 percent of all Medicare Part B laboratory spending

Subscribe to View

Start a Free Trial for immediate access to this article

Try For Free

Already a member? Log in here

2026 Predictions for Clinical Labs: AI, Audits, and Increased Enforcement

by Kelly Bilodeau | Oct 27, 2025 | Compliance-lca, Compliance-nir, DOJ-lca, DOJ-nir, Enforcement-lca, Enforcement-lir, Enforcement-nir, Essential, Lab Industry Advisor, Legislation-lca, Legislation-lir, Legislation-nir, PAMA-lir, Reimbursement-lca, Reimbursement-lir, Reimbursement-nir

How clinical laboratories should prepare for the next wave of oversight in the new year

Subscribe to View

Start a Free Trial for immediate access to this article

Try For Free

Already a member? Log in here

Lawyers Give Their Tips to Spot Clinical Lab Fraud

by Oscelle Boye, MBiomed | Jun 19, 2025 | Compliance-lca, Compliance-nir, Essential, Lab Industry Advisor, OIG-nir

Medical laboratories should monitor fraud cases across the country and also stay vigilant of suspicious patterns of behavior

Subscribe to View

Start a Free Trial for immediate access to this article

Try For Free

Already a member? Log in here

Audits, the False Claims Act and Clinical Lab Enforcement: 2025 Trends and Compliance Tips

by G2 Intelligence Staff | May 6, 2025 | OLP-Regular, Webinars

Original Air Date: Wednesday July 11, 2025 1:00 PM ET Register now to View On-Demand! Significant cases decided in 2024 and 2025 are shaping the landscape of enforcement for clinical laboratories. Government regulators continue to focus on medical necessity and...